Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1990-1-25
pubmed:abstractText
The biological activity of beta-casein derived beta-casomorphin peptides was evaluated by injecting bovine beta-casomorphin-5 (Tyr-Pro-Phe-Pro-Gly), the homologous sequence in human beta-casein (Tyr-Pro-Phe-Val-Glu) and the corresponding N-terminal tetrapeptides into the left substantia nigra of rats. Their ability to produce rotational behaviour was compared to that produced by three reference compounds, morphine, D-ala2D-leu5 enkephalin and U50,488H, ligands for mu, delta and kappa types of opioid receptors, respectively. The relative potencies of beta-casomorphins and morphine were compared to those tested in two in vitro assays for opioid activity: (1) inhibition of the electrically induced contraction of the isolated myenteric plexus-longitudinal muscle of the guinea-pig ileum and (2) displacement of 3H-dihydromorphine binding to brain membranes. The same ranking order of potency was found in all three assays, the peptides from human beta-casein being about 10-fold less potent than those from bovine beta-casein. The effects of both morphine and bovine beta-casomorphin-5 in producing rotational behaviour were antagonized by naloxone; however, approximately 10-fold more naloxone was required to antagonize the beta-casomorphin-5 effect than that of morphine. The present data are discussed in the light of the recent observation that high concentrations of beta-casomorphin-like peptides are found in the cerebrospinal fluid and plasma of women with postpartum psychosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0033-3158
pubmed:author
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
357-61
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:2556724-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benz..., pubmed-meshheading:2556724-Animals, pubmed-meshheading:2556724-Cattle, pubmed-meshheading:2556724-Endorphins, pubmed-meshheading:2556724-Enkephalin, Leucine, pubmed-meshheading:2556724-Enkephalin, Leucine-2-Alanine, pubmed-meshheading:2556724-Guinea Pigs, pubmed-meshheading:2556724-Humans, pubmed-meshheading:2556724-Ileum, pubmed-meshheading:2556724-Injections, pubmed-meshheading:2556724-Male, pubmed-meshheading:2556724-Mitochondria, pubmed-meshheading:2556724-Morphine, pubmed-meshheading:2556724-Muscle, Smooth, pubmed-meshheading:2556724-Pyrrolidines, pubmed-meshheading:2556724-Rats, pubmed-meshheading:2556724-Rats, Inbred Strains, pubmed-meshheading:2556724-Receptors, Opioid, pubmed-meshheading:2556724-Rotation, pubmed-meshheading:2556724-Stereotyped Behavior, pubmed-meshheading:2556724-Substantia Nigra
pubmed:year
1989
pubmed:articleTitle
Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats.
pubmed:affiliation
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't